[HTML][HTML] Aflibercept plus FOLFIRI for second-line treatment of metastatic colorectal cancer: observations from the global aflibercept safety and health-related quality-of …
RP Riechelmann, V Srimuninnimit, R Bordonaro… - Clinical colorectal …, 2019 - Elsevier
Background The objectives of this study were to evaluate the safety profile of aflibercept and
health-related quality of life (HRQL) in patients with metastatic colorectal cancer (mCRC) …
health-related quality of life (HRQL) in patients with metastatic colorectal cancer (mCRC) …
[PDF][PDF] Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality …
RP RIECHELMANN… - Clinical Colorectal …, 2019 - observatorio.fm.usp.br
This study evaluated safety and quality of life in patients with metastatic colorectal cancer
undergoing treatment with aflibercept and FOLFIRI (fluorouracil, leucovorin, irinotecan) …
undergoing treatment with aflibercept and FOLFIRI (fluorouracil, leucovorin, irinotecan) …
[引用][C] Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality …
RP Riechelmann, V Srimuninnimit, R Bordonaro… - Clinical Colorectal …, 2019 - elibrary.ru
Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of …
RP Riechelmann, V Srimuninnimit… - Clinical Colorectal …, 2019 - europepmc.org
Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer:
Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program …
Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program …
[HTML][HTML] Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related …
RP Riechelmann, V Srimuninnimit… - Clinical …, 2019 - clinical-colorectal-cancer.com
Background The objectives of this study were to evaluate the safety profile of aflibercept and
health-related quality of life (HRQL) in patients with metastatic colorectal cancer (mCRC) …
health-related quality of life (HRQL) in patients with metastatic colorectal cancer (mCRC) …
Aflibercept Plus FOLFIRI for second-line treatment of metastatic colorectal cancer: observations from the Global Aflibercept Safety and Health-Related Quality-of-Life …
RP Riechelmann, V Srimuninnimit… - Clinical …, 2019 - repository.uantwerpen.be
This study evaluated safety and quality of life in patients with metastatic colorectal cancer
undergoing treatment with aflibercept and FOLFIRI (fluorouracil, leucovorin, irinotecan) …
undergoing treatment with aflibercept and FOLFIRI (fluorouracil, leucovorin, irinotecan) …
Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of …
R Riechelmann, V Srimuninnimit… - CLINICAL …, 2019 - avesis.hacettepe.edu.tr
This study evaluated safety and quality of life in patients with metastatic colorectal cancer
undergoing treatment with aflibercept and FOLFIRI (fluorouracil, leucovorin, irinotecan) …
undergoing treatment with aflibercept and FOLFIRI (fluorouracil, leucovorin, irinotecan) …
Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of …
RP Riechelmann, V Srimuninnimit… - Clinical Colorectal …, 2019 - epub.ub.uni-muenchen.de
This study evaluated safety and quality of life in patients with metastatic colorectal cancer
undergoing treatment with aflibercept and FOLFIRI (fluorouracil, leucovorin, irinotecan) …
undergoing treatment with aflibercept and FOLFIRI (fluorouracil, leucovorin, irinotecan) …
[引用][C] Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality …
RP Riechelmann, V Srimuninnimit… - Clinical …, 2019 - produccioncientifica.ucm.es
Background: The objectives of this study were to evaluate the safety profile of aflibercept and
health-related quality of life (HRQL) in patients with metastatic colorectal cancer (mCRC) …
health-related quality of life (HRQL) in patients with metastatic colorectal cancer (mCRC) …
Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of …
RP Riechelmann, V Srimuninnimit… - Clinical …, 2019 - pubmed.ncbi.nlm.nih.gov
Background The objectives of this study were to evaluate the safety profile of aflibercept and
health-related quality of life (HRQL) in patients with metastatic colorectal cancer (mCRC) …
health-related quality of life (HRQL) in patients with metastatic colorectal cancer (mCRC) …